4.2 Article

Molecular Aspects of Head and Neck Cancer Therapy

Journal

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
Volume 29, Issue 6, Pages 971-+

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.hoc.2015.07.003

Keywords

Head and neck cancer; Squamous cell carcinoma; Molecular biology; Targeted therapy; Synthetic lethality; Genomic sequencing; Intratumor heterogeneity

Funding

  1. NIDCR NIH HHS [R01 DE022087] Funding Source: Medline

Ask authors/readers for more resources

In spite of a rapidly expanding understanding of head and neck tumor biology and optimization of radiation, chemotherapy, and surgical treatment modalities, head and neck squamous cell carcinoma (HNSCC) remains a major cause of cancer-related morbidity and mortality. Although our biologic understanding of these tumors had largely been limited to pathways driving proliferation, survival, and differentiation, the identification of HPV as a major driver of HNSCC and genomic sequencing analyses has dramatically influenced our understanding of tumor biology and approach to therapy. Here, we summarize molecular aspects of HNSCC biology and identify promising areas for potential diagnostic and therapeutic agents.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available